Monthly Statement of Voting Rights and Capital of Nanobiotix

Nanobiotix, a biotechnology company listed on Euronext Paris and Nasdaq, has released its monthly report on voting rights and shares constituting its share capital. As of March 31, 2026, the total number of shares stood at 48,517,630. The total number of voting rights was 50,165,132 theoretical and 50,143,014 exercisable. These figures are disclosed in accordance with regulations, including Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the French Financial Markets Authority (AMF). Nanobiotix continues its innovation strategy in the field of physical therapies, consolidating its financial stability and its presence in the international market.